Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exon architecture controls mRNA m6A suppression and gene expression. | Science | 2023 | 36705538 | PubTator, text mining | PubMed |
| METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor. | Proc Natl Acad Sci U S A | 2023 | 36693099 | PubTator, text mining | PubMed |
| METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey. | J Med Chem | 2023 | 36692498 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis. | PeerJ | 2023 | 36691477 | PubTator, text mining | PubMed |
| CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification. | J Transl Med | 2023 | 36691046 | PubTator, text mining | PubMed |
| METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability. | Cell Death Discov | 2023 | 36683086 | PubTator, text mining | PubMed |
| Severe Burn Injury Significantly Alters the Gene Expression and m6A Methylation Tagging of mRNAs and lncRNAs in Human Skin. | J Pers Med | 2023 | 36675811 | PubTator, text mining | PubMed |
| A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. | Int J Mol Sci | 2023 | 36675190 | PubTator, text mining | PubMed |
| Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis. | Int J Mol Sci | 2023 | 36675186 | PubTator, text mining | PubMed |
| Modification and Expression of mRNA m6A in the Lateral Habenular of Rats after Long-Term Exposure to Blue Light during the Sleep Period. | Genes (Basel) | 2023 | 36672884 | PubTator, text mining | PubMed |
| Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer. | Cancer Commun (Lond) | 2023 | 36670046 | PubTator, text mining | PubMed |
| A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules. | Chem Rev | 2023 | 36662637 | PubTator, text mining | PubMed |
| Structural insights into DNA N6-adenine methylation by the MTA1 complex. | Cell Discov | 2023 | 36658132 | PubTator, text mining | PubMed |
| The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC). | Evol Bioinform Online | 2023 | 36655172 | PubTator, text mining | PubMed |
| Crosstalk between G-quadruplex and ROS. | Cell Death Dis | 2023 | 36653351 | PubTator, text mining | PubMed |
| The function and clinical implication of YTHDF1 in the human system development and cancer. | Biomark Res | 2023 | 36650570 | PubTator, text mining | PubMed |
| High Throughput FISH Screening Identifies Small Molecules That Modulate Oncogenic lncRNA MALAT1 via GSK3B and hnRNPs. | Noncoding RNA | 2023 | 36649031 | PubTator, text mining | PubMed |
| N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases. | Kidney Int Rep | 2023 | 36644366 | PubTator, text mining | PubMed |
| Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1. | Mol Cancer | 2023 | 36635770 | PubTator, text mining | PubMed |
| A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma. | BMC Pulm Med | 2023 | 36635678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=71